GMED Globus Medical Inc Class A

Globus Medical to Participate as Platinum Sponsor at North American Spine Society Annual Meeting

Globus Medical to Participate as Platinum Sponsor at North American Spine Society Annual Meeting
EN
05/10/2020

Underlying

GMEDGlobus Medical Inc Class A

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Globus Medical Inc Class A

 PRESS RELEASE
Free
GMED Globus Medical ...

Globus Medical Announces $500 Million Share Repurchase Program

Globus Medical Announces $500 Million Share Repurchase Program AUDUBON, Pa., May 15, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that its Board of Directors has authorized a share repurchase program of up to $500 million of the Company’s outstanding common stock. “We believe the recent volatility in our share price has created a meaningful disconnect between our intrinsic value and our market valuation,” said Keith Pfeil, Chief Financial Officer and Chief Operating Officer of Globus Medical. “Given our strong tr...

May 15, 2025 1 EN
 PRESS RELEASE
Free
GMED Globus Medical ...

Globus Medical Reports First Quarter 2025 Results

Globus Medical Reports First Quarter 2025 Results AUDUBON, Pa., May 08, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 2025. Worldwide net sales were $598.1 million, a decrease of 1.4%, or a decrease of 0.8% on a constant currency basisGAAP net income for the quarter was $75.5 millionGAAP diluted earnings per share (“EPS”) was $0.54 and non-GAAP diluted EPS was $0.68 “Our first quarter results were impacted by softer Enabling Technology deal closures, tempo...

May 8, 2025 1 EN
 PRESS RELEASE
Free
GMED Globus Medical ...

Globus Medical Schedules First Quarter Earnings Release and Conference...

Globus Medical Schedules First Quarter Earnings Release and Conference Call AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- , Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first quarter ended March 31, 2025 after the market close on Thursday, May 8, 2025. A copy of the release will be available on the Globus Medical website at . Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 4:30 p.m. Eastern Time. Participants may access the conference call li...

April 17, 2025 1 EN
 PRESS RELEASE
Free
GMED Globus Medical ...

Globus Medical completes acquisition of Nevro Corp.

Globus Medical completes acquisition of Nevro Corp. AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisition of Nevro Corp., a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain. “We are excited to begin the journey of accelerating market penetration of Nevro’s differentiated high-frequency technology and bringing a much-needed treatment option to patients suffering from chron...

April 3, 2025 1 EN
 PRESS RELEASE
Free
GMED Globus Medical ...

Globus Medical extends versatility of Advanced Materials Science™ ante...

Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades AUDUBON, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced two commercial launches: COHERE™ ALIF Spacer: The first Porous PEEK™ interbody spacer for anterior lumbar interbody fusion (ALIF) surgery, andModulus™ ALIF Blades: An extension of the market-leading Modulus™ ALIF interbody spacer system. The COHERE ™ ALIF Spacer is the latest addition to...

March 11, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch